← Back to Search

COVID-19 Breastfeeding Support for Coronavirus (COVID-BF Trial)

N/A
Waitlist Available
Led By Flora A Ukoli, M.D., MPH.
Research Sponsored by Meharry Medical College
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-months postpartum
Awards & highlights
No Placebo-Only Group

Summary

This trial will help African American moms get the support they need to breastfeed, so their babies can get the natural immunity they need against COVID-19.

Eligible Conditions
  • Coronavirus
  • Exclusive Breastfeeding

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-months postpartum
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-months postpartum for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
COVID-19 breastfeeding guidance adherence at 1-month postpartum.
COVID-19 breastfeeding guidance adherence at 3-months postpartum.
COVID-19 breastfeeding guidance adherence at birth.
+3 more
Secondary study objectives
COVID-19 Immunoglobulin G
Immunoglobulin M
COVID_Status
Other study objectives
COVID-19 breastfeeding guideline knowledge score change.
Certified Lactation Consult after delivery.
Certified Lactation Consult in pregnancy.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: COVID BF-SupportExperimental Treatment1 Intervention
COVID-19 breastfeeding guideline education and support for pregnant women.

Find a Location

Who is running the clinical trial?

Meharry Medical CollegeLead Sponsor
18 Previous Clinical Trials
5,784 Total Patients Enrolled
Samuel E Adunyah, Ph.D.Study DirectorMeharry Medical College
Carlton Z Adams, M.D.Study ChairMeharry Medical College
~39 spots leftby Nov 2025